Synopsis
Synopsis
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDA Orange Book
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Metriclavin
2. Ergometrin Maleate
3. D-ergonovine Maleate
4. Ergometrine Acid Maleate
5. Oxytocic
6. Ergot
7. Ergonovine, Maleate (1:1) (salt)
8. Ergonovine Maleate Salt
9. Nsc93752
10. Wln: T C6656 1a P Gn Lm Cutt & & J Evmy1 & 1q G1 & Ov1u1vo
11. (z)-but-2-enedioic Acid;n-(1-hydroxypropan-2-yl)-7-methyl-6,6a,8,9-tetrahydro-4h-indolo[4,3-fg]quinoline-9-carboxamide
12. Ergoline-8-.beta.-carboxamide,10-didehydro-n-((s)-2-hydroxy-1-methylethyl)-6-methyl-, Maleate (1:1) (salt)
13. Ergoline-8-carboxamide,10-didehydro-n-(2-hydroxy-1-methylethyl)-6-methyl-, [8.beta.(s)]-, (z)-2-butenedioate (1:1) (salt)
14. Ergoline-8.beta.-carboxamide,10-didehydro-n-((s)-2-hydroxy-1-methylethyl)-6-methyl-, Maleate (1:1) (salt)
Molecular Weight | 441.5 g/mol |
---|---|
Molecular Formula | C23H27N3O6 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 5 |
Exact Mass | 441.18998559 g/mol |
Monoisotopic Mass | 441.18998559 g/mol |
Topological Polar Surface Area | 143 Ų |
Heavy Atom Count | 32 |
Formal Charge | 0 |
Complexity | 654 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 3 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
58
PharmaCompass offers a list of Ergonovine Maleate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ergonovine Maleate manufacturer or Ergonovine Maleate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ergonovine Maleate manufacturer or Ergonovine Maleate supplier.
PharmaCompass also assists you with knowing the Ergonovine Maleate API Price utilized in the formulation of products. Ergonovine Maleate API Price is not always fixed or binding as the Ergonovine Maleate Price is obtained through a variety of data sources. The Ergonovine Maleate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ermetrin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ermetrin, including repackagers and relabelers. The FDA regulates Ermetrin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ermetrin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ermetrin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ermetrin supplier is an individual or a company that provides Ermetrin active pharmaceutical ingredient (API) or Ermetrin finished formulations upon request. The Ermetrin suppliers may include Ermetrin API manufacturers, exporters, distributors and traders.
click here to find a list of Ermetrin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ermetrin DMF (Drug Master File) is a document detailing the whole manufacturing process of Ermetrin active pharmaceutical ingredient (API) in detail. Different forms of Ermetrin DMFs exist exist since differing nations have different regulations, such as Ermetrin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Ermetrin DMF submitted to regulatory agencies in the US is known as a USDMF. Ermetrin USDMF includes data on Ermetrin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ermetrin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Ermetrin suppliers with USDMF on PharmaCompass.
A Ermetrin CEP of the European Pharmacopoeia monograph is often referred to as a Ermetrin Certificate of Suitability (COS). The purpose of a Ermetrin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Ermetrin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Ermetrin to their clients by showing that a Ermetrin CEP has been issued for it. The manufacturer submits a Ermetrin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Ermetrin CEP holder for the record. Additionally, the data presented in the Ermetrin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Ermetrin DMF.
A Ermetrin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Ermetrin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Ermetrin suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ermetrin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ermetrin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ermetrin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ermetrin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ermetrin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ermetrin suppliers with NDC on PharmaCompass.
Ermetrin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ermetrin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ermetrin GMP manufacturer or Ermetrin GMP API supplier for your needs.
A Ermetrin CoA (Certificate of Analysis) is a formal document that attests to Ermetrin's compliance with Ermetrin specifications and serves as a tool for batch-level quality control.
Ermetrin CoA mostly includes findings from lab analyses of a specific batch. For each Ermetrin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ermetrin may be tested according to a variety of international standards, such as European Pharmacopoeia (Ermetrin EP), Ermetrin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ermetrin USP).